Article

ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATION

2024-05-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> In the past years, there has been a rise on advanced endometrial cancers (EC) patients resulting in mortality increase. To overcome this trend, it is essential to improve the stratification of the risk of post-surgery recurrence and to anticipate the development of disease relapse and resistance to treatment. Liquid biopsy analyses represent a promising tool to address these...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aa9295dd-9c72-5088-91f1-2b25e303524b
DOI: 10.1101/2024.05.20.24307623

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATIONDOI 10.1101/2024.05.20.24307623Read

Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study.Semantic proximity Read

Circulating tumor DNA as a prognostic marker in high-risk endometrial cancerSemantic proximity Read

Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer.Semantic proximity Read

Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and ProgressionSemantic proximity Read

Mutational profile in circulating tumor DNA in a patient affected by low-risk endometrial cancer: predictable tool of relapse?Semantic proximity Read

Utility of circulating tumor DNA for detection and monitoring of endometrial cancer recurrence and progressionSemantic proximity Read

The Application of Liquid Biopsy for the Development and Validation of a Non-Invasive Screening and Diagnosis Test for Endometrial Premalignant and Malignant Lesions: A Prospective Innovative Pilot StudySemantic proximity Read

High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer.Semantic proximity Read

Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer.Semantic proximity Read

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial CancerSemantic proximity Read

The Potential of Liquid Biopsy in Detection of Endometrial Cancer Biomarkers: A Pilot Study.Semantic proximity Read

Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.Semantic proximity Read